A comprehensive view of Schott Group (Schott Pharma). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Schott Pharma granted patent for film and decontaminable packaging made of flashspun or spunbonded, selectively permeable nonwoven that offers sterile environments for medical, pharmaceutical, cosmetic, transportation, storage applications: USPTO 11912008
Published: April 05, 2024 by Chemicals & Chemistry Business Daily
SCHOTT Pharma to invest US$371.0M in a new manufacturing facility in Wilson, North Carolina; facility to make glass and polymer prefillable syringes to meet the need for deep-cold storage and transportation of mRNA medications, create over 400 jobs
Published: March 19, 2024 by Business Wire
Schott Pharma reports 9% year-over-year revenue boost to €899.0M in FY2023 driven by production expansion and new lines for pre-fillable polymer syringes; announces investment in new containment and delivery site in Serbia
Published: December 21, 2023 by FiercePharma
Schott’s medical packaging unit, Schott Pharma, will become a public company later in year; Schott will list the medical glass division on the Frankfurt Stock Exchange, and the IPO could draw a valuation of €4B, a source told Reuters in June
Published: September 06, 2023 by FiercePharma

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count